Search Results 1411-1420 of 16222 for monoclonal antibody

  1. Publications - Saad J. Kenderian, M.B., Ch.B. - Mayo Clinic

    Zirconium- 89 Labeled Antibody K1-70 for PET ... monoclonal B cell lymphocytosis. Am J Hematol ... The CLL International Prognostic Index predicts outcomes in ...

  2. Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia - Mayo Clinic

    NOTE: Patients with antibody to hepatitis B core antibody are eligible if they have no measurable viral titer. Patients who have had a hepatitis B virus ...

  3. Carfilzomib and Dexamethasone in Treating Patients With Multiple Myeloma Who Previously Underwent a Stem Cell Transplant - Mayo Clinic

    Serum monoclonal protein ≥ 1.0 g/dL; ≥ 200 mg of monoclonal protein in the urine on 24 hour electrophoresis; Serum immunoglobulin free light chain ≥ 10 mg ...

  4. Publications - Kevin H. Luk, M.D. - Mayo Clinic

    2007; 24(6):686. Munson EL, Nardelli DT, Luk KH, Remington MC, Callister SM, Schell RF. Interleukin-6 promotes anti-OspA borreliacidal antibody production in ...

  5. Clinical trials - Oncology (Medical)

    The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and chronic ...

  6. Open-label, Multi-center, Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Autologous CAR-BCMA T-cells (CT053) in Patients

    Patients have plasma cell leukemia, Waldenström macroglobulinemia, POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin ...

  7. Publications - Michael P. Fautsch, Ph.D. - Mayo Clinic

    Epub 2008 Aug 21. View PubMed; Ezzat MK, Howell KG, Bahler CK, Beito TG, Loewen N, Poeschla EM, Fautsch MP. Characterization of monoclonal antibodies against ...

  8. Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

    Receipt of any type of anticancer antibody (including investigational antibody) or systemic chemotherapy within 4 weeks before first dose of study treatment ...

  9. Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma - Mayo Clinic

    positive hepatitis B core antibody (anti-HBc) and negative HBsAg require hepatitis B polymerase chain reaction (PCR) evaluation. Patients who are hepatitis ...

  10. Study of MK-8242 Alone and in Combination with Cytarabine in Participants with Acute Myelogenous Leukemia (P07649) - Mayo Clinic

    Clinically significant hepatitis at Screening, or hepatitis C antibody positive, hepatitis B surface antigen positive, or human immunodeficiency virus (HIV) ...